





HSUS seeks to end 
rabbit blinding tests 
Annually, 65 to 100 million animals are being used as test 
subjects in the laboratories of cosmetic companies, drug manu­
facturers, university and commercial research centers, and pro­
ducers of household products. The Humane Society of the 
United States has taken the position that much of this test­
ing is not only unreliable, but also results in unnecessary pain 
and death. 
Cats, dogs, birds, rats, mice, monkeys, and rabbits are 
just some of the animals routinely subjected to electric 
shocks, rubber riot control bullets, huge doses of 
radiation, and chemical solutions. 
The research industry has long held that the 
use of animals is the only "reliable" way we have 
of determining the safety of a cosmetic, drug, or 
household product. Over the years this belief has 
served to support scientists as they subjected ani-
mals to many tests. The American public has seen 
little of the massive animal suffering that has 
taken place in the research labs. 
Today, a new debate is taking 
place. People from all walks of life 
are asking if all the suffering and 
death is worth it. Many research 
scientists have joined the ranks of 
those who are questioning the sci­
entific and ethical foundation of 
using animals for research sub­
jects. Scientists have developed 
new techniques utilizing tissue cul­
tures, computer models, and bacteria 
which can be used to test the safety of 
substances. 
One of the most outrageous tests currently 
being used is the Draize test to determine the eye 
irritancy of substances. Drops of soap, perfume, 
and other common products are put into the eyes of 
albino rabbits to find out if these things are harmful 
to human eyes. Because of the pain and suffering which 
are created by the Draize test which is unreliable, The 
HSUS has formally asked government regulatory 
agencies to find alternatives to the test. "Some knowl­
edge can be obtained at too high a price," says phys­
iologist Dr. D.H. Smyth in his book, Alternatives to 
Animal Experiments. 
----- ------ -------------------------------
What is the Draize Test? 
More than 35 years ago, Dr. J.H. Draize and 
several of his colleagues at the Food and Drug Ad­
ministration (FDA) developed a test to assess the eye 
irritancy of chemicals and mixtures of chemicals. 
This Draize test is now routinely used on albino rab­
bits to test cosmetics, toiletries, pesticides, drugs, and 
other chemicals before they are put on the market. 
The Draize test involves, or can involve, a great 
deal of pain. It provides crude information on 
whether or not a substance will irritate human eyes. 
Because of the animal suffering involved and the 
poor quality of the information obtained, The 
Humane Society of the United States along with a 
coalition of more than 300 local animal welfare 
groups has asked FDA, other agencies, and the 
cosmetic industry to devote time and money to the 
development of an alternative to the Draize test 
which does not involve the use of animals. 
Federal regulations specify that albino rabbits 
must be used in eye irritancy studies. The rabbits' 
eyes are by no means ideal substitutes for human 
eyes. The corneas of rabbits' eyes are thinner than 
human corneas and rabbits have far less efficient tear 
glands. Although the nictitating membrane in rabbits' 
eyes may compensate for the lack of the cleansing ef­
fect of tears, this is by no means certain. 
Six to nine rabbits are used for each test. One eye 
of each rabbit is left untreated to serve as a control, 
while the test substance is forced into the other eye. 
The rabbits may or may not be restrained in stocks, 
as shown in the photo. Observations are made 1, 24, 
48, 72, and 168 hours after treatment. The substance 
is then scored on a scale ranging from O to 110 
developed by Draize and his colleagues which relies 
on the following features: 
(a) the development of opaqueness in the cornea, 
(b) inflammation in the iris, 
(c) inflammation of the conjunctivae. 
The total score is meant to give some measure of the 
irritancy potential of the test substance. 
Twenty-seven years after the Draize test had been 
developed, two American toxicologists conducted a 
major survey of its reliability. They distributed 
twelve compounds to twenty-four government and 
industrial laboratories, including Avon, Colgate­
Palmolive, General Foods, American Cyanamid and 
the Food and Drug Directorate in Canada. Each was 
to follow a set procedure in assessing the eye irritancy 
of each compound. The Draize test was found to be 
unreliable. 
Three of the substances were so mild that no 
laboratory reported them as irritants. However, there 
was wide variation on each of the remaining nine 
substances. For example, after 24 hours, one labora­
tory reported a median score of 7 for ethoxylated 
lauryl alcohol while another gave it a 79. These were 
Rabbit being held to show eyeball and conjunctiva! 
sac into which sample for testing is placed. 
the extreme scores from the twenty-four different 
laboratories; but it means that one would report the 
alcohol as being highly irritant, while another would 
report it as being a non-irritant. It is hardly surprising 
that, when the report appeared in 1971, the authors 
concluded that: 
"Rabbit eye and skin procedures current­
ly recommended by the federal agencies 
for use in the delineation of irritancy of 
materials should not be recommended as 
standard procedures in any new regula­
tions. Without careful reeducation, 
these tests result in unreliable results." 
The FDA conducted a follow-up study and con­
cluded that the data in the 1971 report was essentially 
correct. However, the FDA authors placed a differ­
ent interpretation on the results. They argued that 
the 1971 study had made the mistake of using the 
Draize test to attempt to discriminate between differ­
ent grades of irritants. Instead, the Draize test should 
only be used to distinguish an irritant from a non­
irritant and not to determine the degree of irritancy. 
Using this caveat, the FDA scientists argued that the 
Draize test could be used to evaluate the safety of a 
substance in a simple pass-fail manner. Even in this 
pass-fail situation, there is still no guarantee that a 
substance which is a non-irritant in a rabbit will be a 
non-irritant in a human eye and vice versa. 
Despite the clear problems associated with the 
Draize test and disagreement among scientists, it is 
still being recommended as a standard test for eye 
irritants by federal agencies. 
The HSUS bas sent detailed arguments to the gov­
ernment agencies involved, outlining why the Draize 
test should be dropped and asking them to immedi­
ately fund research into alternatives. As part of the 
arguments, The HSUS pointed out that there are 
three interlocking elements which lead to the in­
evitable conclusion that the Draize test can no longer 
be justified as a routine test for eye irritancy. 
(1) The test will cause suffering and, in some cases, 
a great deal of suffering to the rabbits being used. 
Many toxicological technicians have expressed strong 
feelings against the test, especially in those instances 
where the rabbits scream when the test substance is 
introduced into the eye. 
(2) The information produced by the test is crude 
at best and totally unreliable at worst. Where routine 
testing is carried out, a test should be highly repro­
ducible, especially when many different laboratories 
are involved. 
(3) The prospects for developing an alternative to 
the Draize test are very good. However, time and 
money are required, and no government agency or 
commercial organization has yet devoted sufficient 
time, money, or energy to the task. The techniques 
are available, but the will to select the best one and to 
validate it has, so far, been lacking. 
What are the Alternatives? 
In April, 1978, a contract research organization in 
England reported on the results of some preliminary 
work to develop a cell culture alternative to the 
Draize test. Three shampoos of known irritancy 
(low, moderate, and high) were tested. In all cases, 
the cell system distinguished between shampoos of 
high and low irritancy. The cell test did not reliably 
distinguish between the moderately irritant shampoo 
and the other two. The organization stressed that the 
results are preliminary and the discriminatory powers 
of the test need to be improved. They concluded 
there is "a basis for an in vitro system for the screen­
ing of severe irritants as an alternative to the Draize 
test." Partly as a result of this work and of consumer 
pressure, several cosmetic companies in England 
have collaborated to support further research by a 
single scientist on tissue culture tests for screening 
irritants. 
The Results Aren't Pretty! 
The above photographs show four grades of rabbit opacity. The final picture shows an eye which 
eye reaction to irritants. The first picture on the left achieves maximum marks (4) for cbemosis (swelling 
shows a normal eye. The second picture shows an eye of conjunctivae due to fluid collection in cells and 
with maximum marks (3) for redness. The third pie- between cells). As one might imagine, any substance 
ture demonstrates what is meant by the development which produces a reaction this severe is also likely to 
of opacity. This eye achieves maximum marks (4) for cause a lot of pain. 
The Cosmetic Industry and the Draize Test 
The cosmetic and toiletries industry is currently 
estimated at a $10 billion per annum market. About 
4,000 companies manufacture and sell cosmetics. 
However, only ten companies control approximately 
three-fifths of the total market with Avon, Bristol 
Myers, Revlon, and Proctor & Gamble leading the 
industry in 1977, followed by Colgate-Palmolive, 
Gillette, and Chesebrough-Ponds, according to a 
market survey by Frost & Sullivan. 
Some companies do no animal testing and yet 
market safe products. The reasons for this lack of 
animal testing differ. For example, Yardley claims to 
do no animal testing, but this is because their product 
ines have been on the market for a long time and 
they have developed no new products which would 
require additional testing. If they were to develop 
new products, they probably would test on animals. 
Some companies do no animal testing because of 
their ethical stand against the use of animals or 
animal products. However, companies which take an 
ethical stand against animal testing are tiny when 
compared to the industry giants and their products 
are difficult to obtain except in health food stores. 
The cosmetic industry as a whole should be urged 
to make a positive commitment to deal with the 
problem of animal testing by developing and validat­
ing adequate alternatives. There have been a number 
of initiatives to pressure the industry into making a 
positive commitment to "alternatives" but, so far, 
without success. The most recent and probably most 
detailed effort was launched by the Coalition to Stop 
Draize Rabbit Blinding Tests. After a number of ef­
forts to interest Revlon to seek alternatives, HSUS's 
Dr. Rowan and Mr. Spira of the Coalition met with 
the Revlon Vice-President of Public Affairs. As a 
result of that meeting, the Coalition was invited to 
put forward a proposal for Revlon's consideration. 
The proposal pointed out the scientific and ethical 
problems of the Draize test. It asked Revlon, as one 
of the leaders of the cosmetic industry, to approach 
the Cosmetic, Toiletry and Fragrance Association 
with a proposal that the CTFA should organize a col­
laborative effort by the industry to develop an alter­
native to the Draize test which does not involve the 
use of live animals. As part of the proposal, it was 
suggested that Revlon should allocate one hundredth 
of one percent of its gross annual sales to the project 
as an indication of good faith. 
Revlon referred the proposal to the CTFA's Com­
mittee on Pharmacology and Toxicology for consid­
eration by a subcommittee which had been estab­
lished to review short-term testing procedures for the 
industry. Part of Revlon's response to the Coalition's 
proposal reads as follows: "Neither Revlon, nor any 
other single company, can give any assurances as to 
what action, if any, this committee, or any other 
committee of the CTFA, may take on this matter, ex­
cept to say that it will receive consideration. "Neither 
the Coalition nor HSUS consider this to be an ade­
quate response. If Revlon had committed funds to 
the idea of developing an alternative prior to refer-
ring the proposal to the CTFA, it might have stood a 
better chance of acceptance. Without Revlon's sup­
port, the outcome looks bleak. 
Humane Groups form 
Coalition to Abolish 
Draize Test 
The creation of Henry Spira, a New York City 
teacher, the Coalition is sponsored by The HSUS and 
other national groups. Several HSUS staff members, 
including Dr. Andrew Rowan of the Institute for the 
Study of Animal Problems and HSUS President 
John A. Hoyt, are working closely with Mr. Spira, 
who is serving as coordinator. More than 300 local 
animal welfare groups have added their support to 
the Coalition in response to a national appeal. 
A number of steps have already been taken by the 
Coalition. These initiatives include letters to federal 
agencies, an approach to the Cosmetic, Toiletry and 
Fragrance Association, and a specific proposal to 
Revlon to help with the development of an alterna­
tive to the Draize test. 
Unless the company gives some early indication 
that it will actively support the development of an al­
ternative to the Draize test, the Coalition is prepared 
to consider other measures, including the possibility 
of enlisting consumer buying power by requesting 
concerned humanitarians to stop buying Revlon 
products. 
An old type of stock used for restraining rabbits for experimental purposes. One rabbit is struggling to free 
itself. 
The Bureaucratic Maze and the Draize 
There are several federal agencies which require 
eye irritancy testing-either explicitly or implicitly. 
These include the Consumer Product Safety Com­
mission, the Food and Drug Administration, and the 
Environmental Protection Agency. The chart out­
lines their areas of responsibility and the enabling 



























Both EPA and CPSC have based their eye irritan­
cy test requirements on the Draize method in which 
the albino rabbit must be used. With regard to cos­
metics, the FDA has no authority to require test data 
prior to marketing of a new product, but each new 
product must either be "adequately substantiated for 
safety" or bear a warning statement that "the safety 






and Analysis (CPSC) 
Washington, D.C. 20207 
Office of Pesticide 
Programs 
EPA 





and consumer items 
consisting of mix­
tures of chemicals 
Pesticides 
Office of Toxic Substances Chemicals not 
EPA covered by other 
Washington, D.C. 20460 three acts 
Division of Cosmetics 
Technology 
FDA, 200 C Street, S.W. 
Washington, D.C. 20024 
Includes cosmetics, 
ophthalmic products 
and other therapeutic 
agents. 
Ohio Court Rules on Draize Test 
In January, 1974, the Food and Drug Ad­
ministration (FDA) went to court against the 
producers of Beacon Castile Shampoo with 
Lanolin. A young girl using the shampoo had 
suffered eye damage after some shampoo had 
gotten into her eye. The Northern District 
Court of Ohio ruled in favor of the company. 
The court said FDA had: (a) failed to show 
that the shampoo was any more hazardous 
than similar products on the market, and (b) 
failed to show that the results of tests on rabbit 
eyes can be extrapolated to humans. The FDA 
had determined that the shampoo was an irri­
tant by means of the Draize test. 
The court also ruled FDA had failed to show 
that the full concentrate of shampoo might get 
into the user's eye under normal conditions of 
use and that the user would not. ordinarily 
flush the shampoo out of the eye immediately. 
In a memorandum dated Feburary 6, 1974, 
the FDA legal counsel argued that the FDA 
should, in the future, have sound evidence and 
a consistent medical and scientific rationale for 
charging potential injury to health. The impli­
cations of this argument are that the Draize 
test does not provide sound evidence for the 
court; and, therefore, it is arguable whether 
the test provides evidence to establish the safe­







Support HSUS Efforts 
To Stop the Use of 
The Draize Test 
It causes pain and it's unreliable, yet governme.nt 
agencies and cosmetic companies are still using the 
Draize test. Why? Because they haven't chosen to ex­
plore potential alternative techniques. The economic 
incentive to find a new test for eye irritancy is not 
present. It's fairly inexpensive to use the rabbits. 
Alternatives may cost less but the difference is not 
enough to spur action. 
Reason has not worked. Economic, social, and 
political pressure are the tools we must employ to end 
the use of this cruel test. The federal agencies and the 
cosmetic companies must be convinced of our deter­
mination to end the pain and suffering to defenseless 
creatures. 
Your support is urgently needed for a victory on 
the Draize test. 
Your individual action is important, but equally 
important is the united action of the Draize Coalition 
and The HSUS. Funds are needed to continue to 
carry on personal contacts, letter writing campaigns, 
and scholarly research required to make the research 
community employ alternative testing methods. 
Send your tax-deductible contribution to The 
HSUS today. Join forces with The HSUS in this 
essential movement to protect our fellow creatures. 
Remember, just saying you like animals is not 
enough! 
What You Can Do 
v Buy cosmetics which have been on the market for 
a long time. Usually, well-established or well-known 
fragrances, lipsticks, powders, etc., which have been 
marketed for some time have not been tested on 
animals. 
v Make an effort to find out if the products you 
regularly use have been tested on animals. Ask sales 
clerks, write to the companies, read the labels. 
v Write to the Cosmetic, Toiletry and Fragrance 
Association, 1133-ISth Street, N.W. Washington, 
D.C. 20005, stating your objection to the Draize test. 
Ask that they orchestrate a collaborative effort by 
the industry to develop alternatives. They may send 
you a pamphlet entitled: "Animal Testing: What are 
the Choices?" This pamphlet is directed to the whole 
field of animal testing and not just the Draize test. 
React to the pamphlet! Write back and explain the 
results on the 1971 survey which revealed the unrelia­
bility of the Draize test. Tell them about the Ohio 
court case. Send copies of letters and replies to The 
HSUS. 
v Write to the Food and Drug Administration 
stating your objection to the Draize test. Ask that 
FDA begin the search for an alternative now! 
v Write to the cosmetics companies themselves. 
Urge them to support the search for alternatives. Ask 
them to allocate one-hundredth of one percent of 
gross annual sales to finding an alternative as sug­
gested by the Coalition. Stress your objections to the 
use of rabbits by them or companies they have con­
tracted with for research. Remember, every letter is 
valuable. Some companies will initiate action after 
receiving very few letters. 
v Use the elements of this Close-Up Report to write 
a letter. to the editor of your local newspaper. Send 
copies to HSUS. 
v Write letters to the editors of magazines you read, 
especially magazines which carry cosmetic advertis­
ing. Your letter might be printed. Or, better yet, you 
may give an editorial person an idea for a story. 
Additional copies of this report are available upon request at 10¢ each. 
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